Search for: "Amgen Inc" Results 41 - 60 of 696
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Oct 2011, 4:56 am by Lawrence B. Ebert
Maxygen, Inc. brought an inter partes re-examination of Amgen's U.S. [read post]
8 Jan 2020, 8:57 pm by Patent Docs
The Federal Circuit provided an answer, at least with regard to the interplay between "comprising" and Markush group language ("selected from the group consisting of") in one of its first opinions of the New Year, Amgen Inc. v. [read post]
20 Sep 2023, 1:30 pm by Eileen McDermott
Court of Appeals for the Federal Circuit (CAFC) today affirmed a district court’s grant of summary judgment that Baxalta, Inc. and Baxalta GmbH’s Hemophilia patent claims are invalid for a lack of enablement. [read post]
20 Sep 2023, 1:30 pm by Eileen McDermott
Court of Appeals for the Federal Circuit (CAFC) today affirmed a district court’s grant of summary judgment that Baxalta, Inc. and Baxalta GmbH’s Hemophilia patent claims are invalid for a lack of enablement. [read post]
25 Jun 2021, 4:15 am by Logan Murr
On June 21, the United States Court of Appeals for the Federal Circuit (CAFC) denied a petition for rehearing and rehearing en banc filed by Amgen Inc., Amgen Manufacturing, Limited, and Amgen USA, Inc. [read post]
16 Jan 2019, 9:42 pm by Patent Docs
Noonan -- The Supreme Court denied certiorari last week in Amgen Inc. v. [read post]
10 Sep 2015, 8:29 am by John Jascob
Current and former employees of Amgen, Inc. filed a class action under ERISA after their employer-sponsored pension plans lost significant value due to concerns about the safety of certain Amgen drugs. [read post]
18 May 2023, 12:15 pm by Gene Quinn
Earlier today, the United States Supreme Court issued its decision in Amgen, Inc. v. [read post]
18 May 2023, 12:15 pm by Gene Quinn
Earlier today, the United States Supreme Court issued its decision in Amgen, Inc. v. [read post]
17 Apr 2007, 8:58 pm
By Sherri Oslick -- In a recent press release, ARIAD Pharmaceuticals, Inc. announced that it has filed suit against Amgen Inc., certain Amgen affiliates, and Wyeth for infringement of U.S. [read post]